The lifetime distribution of the incremental societal costs of autism.

By Michael L. Ganz. Archives of Pediatrics & Adolescent Medicine, 2007

670 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Global Prevalence of Autism and Other Pervasive Developmental Disorders (2012, background): “While existing estimates are variable, the evidence reviewed does not support differences in PDD prevalence by geographic region nor of a strong impact of ethnic/cultural or socioeconomic factors.”
Mapping early brain development in autism. (2007, neutral): “…revealed that increasing interest or attention to the faces by showing familiar faces (Pierce et al., 2004) or increasing gaze ﬁxation to the face by inserting a dot on the face and in-structing subjects to attend to the face results in more normal fusiform activity (Hadjikhani et al., 2004, 2007).”
Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model (2010, background): “Exclusion criteria included (1) a neurodevelopmental disorder of known etiology (eg, fragile X syndrome), (2) significant sensory or motor impairment, (3) major physical problems such as a chronic serious health condition, (4) seizures at time of entry, (5) use of psychoactive medications, (6) histo”